XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Cash Flows Provided by (Used In) Operating Activities    
Net loss $ (18,914,000) $ (282,273,000)
Adjustments to reconcile net loss to net cash and restricted cash used in operating activities:    
Change in fair value of contingent consideration and indemnification asset (594,000) (3,062,000)
(Gain) loss on disposal of assets (1,904,000) 6,447,000
(Gain) loss from equity method investees (12,662,000) (24,731,000)
Depreciation and amortization expenses 30,263,000 31,916,000
Impairment of equity method investments 0 47,133,000
Stock-based compensation expense 7,359,000 7,211,000
Deferred tax (benefit) provision (268,000) (892,000)
Amortization of contract cost assets 8,311,000 10,272,000
Amortization of deferred financing costs 8,837,000 6,079,000
Interest from customer advance for regulatory capital requirements 0 (1,316,000)
Gain on transfer of membership (22,969,000) 0
Goodwill impairment 0 215,100,000
Loss on repayment of debt 19,158,000 0
Other current operating cash outflows, net (729,000) 224,000
Changes in assets and liabilities, net of acquisitions:    
Accounts receivable, net and contract assets (120,066,000) (23,946,000)
Prepaid expenses and other current and non-current assets (3,439,000) (3,912,000)
Contract cost assets (3,991,000) (5,503,000)
Accounts payable 9,904,000 11,690,000
Accrued liabilities (17,725,000) 4,071,000
Accrued compensation and employee benefits (21,505,000) (10,118,000)
Deferred revenue 2,490,000 (6,400,000)
Reserve for claims and performance-based arrangements 62,614,000 33,259,000
Right-of-use operating assets 4,621,000 3,620,000
Operating lease liabilities (2,719,000) 1,783,000
Other long-term liabilities 1,518,000 473,000
Net cash and restricted cash provided by (used in) operating activities (72,410,000) 17,125,000
Cash Flows Provided by (Used In) Investing Activities    
Cash paid for asset acquisitions (1,472,000) 0
Proceeds from transfer of membership and release of Passport escrow 42,996,000 0
Disposal of non-strategic assets and divestiture of discontinued operations, net 3,490,000 (2,287,000)
Return of equity method investments 9,372,000 0
Purchases of investments (2,994,000) (1,447,000)
Maturities and sales of investments 500,000 3,099,000
Investments in internal-use software and purchases of property and equipment (11,512,000) (17,455,000)
Other investing activities 0 (292,000)
Net cash and restricted cash provided by (used in) investing activities 40,380,000 (18,382,000)
Cash Flows Provided by (Used In) Financing Activities    
Changes in working capital balances related to claims processing on behalf of partners 2,399,000 26,715,000
Repayment and termination of Credit Agreement including settlement of warrants. (98,420,000) 0
Proceeds from stock option exercises 9,376,000 526,000
Distributions to Sponsors (1,300,000) 0
Taxes withheld and paid for vesting of restricted stock units (3,142,000) (1,331,000)
Net cash and restricted cash provided by (used in) financing activities (91,087,000) 25,910,000
Effect of exchange rate on cash and cash equivalents and restricted cash (54,000) 26,000
Net increase (decrease) in cash and cash equivalents and restricted cash (123,171,000) 24,679,000
Cash and cash equivalents and restricted cash as of beginning-of-period [1] 361,581,000 128,531,000
Cash and cash equivalents and restricted cash as of end-of-period [1] $ 238,410,000 $ 153,210,000
[1] As a result of the closing of the sale of True Health SPA, the consolidated statements of operations, consolidated balance sheets, and related financial information reflect the Company’s operations and assets and liabilities of True Health as discontinued operations for all periods presented. Cash flows and comprehensive income have not been adjusted and are included in the consolidated statements of cash flows and consolidated statements of comprehensive income (loss) for all periods presented. See Note 5.